An effective allergy fighter might also reduce risk of upper respiratory infections

All Aboard!

A child is a Grand Central Station of germs.

A typical active child touches everything, does a poor job of washing his hands, puts his fingers in his mouth frequently, doesn’t cover his face when he coughs or sneezes, and still shares toys, juice boxes and just about anything else with other kids who have colds.

So if you have a child in your home, or if you spend time with the kids in your family, you’re constantly exposed to their big, wide, not-so-wonderful world of germs.

Want to minimize that exposure?

Squirt a little powdered plant extract up the nose. That should do the trick.

Ahead of the curve

Eight years ago I first told you about Nasaleze–an organic powdered plant extract that creates a mucus-like gel when it’s sniffed into the nasal passage. For those with allergies, the gel provides protection from pollen, ragweed, and pet dander. In other words, the gel does what their nasal passages should do naturally.

Recently, the Wall St. Journal finally caught up with me, featuring Nasaleze in an article about “pollen blockers.” The idea is simple and brilliant: Block the antagonists that cause allergy symptoms and you won’t need drugs to treat the symptoms.

Over the years I’ve told you about several Nasaleze studies. One of them, highlighted in the Wall St. Journal piece, followed 50 children with seasonal allergies. For six weeks, half the group used Nasaleze and half used conventional treatments. Overall, the Nasaleze group reported a steady decrease of allergy symptoms compared to the control group.

Side effects? Zero. The cellulose powder in Nasaleze is inert, so it’s never absorbed by the body, which makes it safe for pregnant women, nursing mothers, and even very young children.

Which brings us to the newest Nasaleze study. In this one, Moscow Medical Academy researchers tested Nasaleze Travel, which is formulated for extra defense against airborne germs.

Nasaleze Travel contains wild garlic extract, which has biologically active components that are naturally antiviral, antifungal, and antibacterial. To test Nasaleze Travel as a preventive against upper respiratory tract infection (URTI), the Moscow team recruited more than 60 children (aged three to 14) who experienced acute URTI at least six to 12 times each year.

For six weeks, one group used Nasaleze Travel twice daily, while the other group received conventional treatments as needed.

Results: Coughing, sneezing, daytime nasal congestion, and nighttime nasal congestion were all improved in the Nasaleze group, but not the control group.

In the control group, each child became ill with URTI at least once during the study period, and nearly half became ill twice. In the Nasaleze group, 80 percent of the kids were healthy and illness-free throughout the study. Among those who did become ill, URTI duration was decreased by 2.5 days compared to the amount of time they were ill the year before.

You can find more information about Nasaleze and Nasaleze Travel at nasaleze.com (which you may already have bookmarked from eight years ago).

To Your Good Health,

Jenny Thompson

Sources:
“Use of Nasaleze Travel as a prevention method for acute respiratory illnesses in paediatric practice” Presented June 2010 at the 29th European Academy of Allergy and Clinical Immunology, London, UK, eaaci.net
“Products Act as a Screen To Protect Against Pollen” Laura Johannes, Wall St. Journal, 9/7/10, online.wsj.com